Mr. Pearlman, a.k.a. “Oz the Mentalist,” is a professional disorienter. He’s a practitioner of mentalism, a subset of magic ...

Most Wall Street analysts view The Trade Desk stock as undervalued despite competition from the likes of Amazon and Google.

The S&P 500 Index ($SPX) (SPY) on Tuesday closed unchanged, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.47%, ...

During the Second World War a brooch inscribed with ancient Norse runes (letters) was discovered in a field at Værløse Airfield in Denmark telling a sinister story of the Nazi’s efforts to abuse ...

We came across a bullish thesis on The Middleby Corporation on Iceman Capital’s Substack. In this article, we will summarize ...

Viking Therapeutics VKTX reported a third-quarter 2025 loss of 81 cents per share, wider than the Zacks Consensus Estimate of a loss of 70 cents. The company had incurred a loss of 22 cents per share ...

In the latest close session, Alphabet Inc. (GOOG) was down 1.14% at $244.36. The stock's performance was behind the S&P 500's daily gain of 0.26%. Meanwhile, the Dow gained 0.15%, and the Nasdaq, a ...

Alphabet Inc. is priced for 11.48% real EPS growth over 10 years, a rate that is below historical performance but roughly in line with consensus estimates. Alphabet's premium valuation reflects strong ...

Alphabet's artificial intelligence (AI) model, Gemini, achieved a significant milestone at a prestigious international competition. Gemini demonstrated AI is on the path to artificial general ...

NASA's Viking landers were the first spacecraft to successfully touch down on the surface of Mars. NASA/JPL-Caltech via AP Finding life beyond the Earth would be a major scientific discovery with ...

Investors spent the early part of this year worried about Alphabet Inc.’s artificial-intelligence positioning and Google’s potential to be disrupted by Department of Justice scrutiny. Now with Gemini ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best biotech stocks with high potential. H.C. Wainwright analyst Joseph Pantginis reiterated a bullish stance on Viking Therapeutics, Inc. (NASDAQ ...